RBD-7022 is under clinical development by Suzhou Ribo Life Sciences and currently in Phase I for Hyperlipidemia.

Biologists at Indiana University Bloomington have shown that the surfaces of plant leaves are coated with a diverse array of ...

Background and objective Gastric cancer (GC) remains a prevalent and preventable disease, yet accurate early diagnostic ...

Silence Therapeutics ( (SLN) ) has shared an announcement.

Through last year, scientists were at work reshaping human life and equipping it, and the world, for the challenges of the ...

Anthem BioScience Ltd. filed its preliminary papers with the Securities and Exchange Board of India on Tuesday to raise Rs ...

From Zildjian to NASA 😮 By Andrew Rosenblum Posted on Dec 26, 2024 To keep global temperatures from rising more than 1.5 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ATLANTA — Georgia prosecutors called on a state appeals court to reject President-elect Donald Trump's bid to dismiss the election interference case against him, saying his arguments are ...